news
A study has shown that type II kinase inhibitors targeting…
29 January 2020 | By Hannah Balfour (Drug Target Review)
A study has shown that type II kinase inhibitors targeting CDK8 alone are ineffective because mutations leave them inactive, suggesting future therapies should target CDK8 in complex.